Rational Design and Synthesis of D‐galactosyl Lysophospholipids as Selective Substrates and non‐ATP‐competitive Inhibitors of Phosphatidylinositol Phosphate Kinases
作者:Mengxia Sun、Chi Zhang、Dexin Sui、Canchai Yang、Dohun Pyeon、Xuefei Huang、Jian Hu
DOI:10.1002/chem.202202083
日期:2023.1.9
and non-ATP-competitive inhibitors of phosphatidylinositol phosphate kinases, which are validated drug targets for deadly human diseases including cancers, amyotrophic lateral sclerosis, and SARS-COVID-2 infection. Rational Design and Synthesis of D-galactosyl Lysophospholipids as Selective Substrates and non-ATP-competitive Inhibitors of Phosphatidylinositol Phosphate Kinases (X. Huang, J. Hu et al
New-to-Nature D-半乳糖基溶血磷脂经过合理设计和合成,可作为磷脂酰肌醇磷酸激酶的人工底物和非 ATP 竞争性抑制剂,磷脂酰肌醇磷酸激酶是经过验证的致命人类疾病(包括癌症、肌萎缩侧索硬化和 SARS- COVID-2 感染。D-半乳糖基溶血磷脂作为磷脂酰肌醇磷酸激酶的选择性底物和非 ATP 竞争性抑制剂的合理设计和合成(X. Huang、J. Hu 等人)